-
Fedratinib, sold
under the
brand name Inrebic, is an anti-cancer
medication used to
treat myeloproliferative diseases including myelofibrosis. It is used...
-
survival has been
recently questioned. In
August 2019, the FDA
approved fedratinib (Inrebic) as a
treatment for
adults with intermediate-2 or high-risk primary...
- 16
August 2019.
Retrieved 16
August 2019. "U.S. FDA
Approves Inrebic (
Fedratinib) as
First New
Treatment in
Nearly a
Decade for
Patients With Myelofibrosis"...
- of
rheumatoid arthritis,
psoriatic arthritis, and
ulcerative colitis;
fedratinib, and ruxolitinib. The
substance is
quickly absorbed from the gut with...
-
Ponatinib Radotinib Src (Bosutinib Dasatinib) J****
kinase (JAK)
Baricitinib Fedratinib Filgotinib Lestaurtinib Momelotinib Pacritinib Ruxolitinib MAP2K (MEK)...
-
announced it
would acquire Impact Biomedicines for $7 billion,
adding fedratinib, a
kinase inhibitor with
potential to
treat myelofibrosis. Also in January...
-
Lapatinib L01EH02
Neratinib L01EH03
Tucatinib L01EJ01
Ruxolitinib L01EJ02
Fedratinib L01EJ03
Pacritinib L01EJ04
Momelotinib L01EK01
Axitinib L01EK02 Cediranib...
-
approved for
clinical use, it is
still used for
research in the area.
Fedratinib Pacritinib Meyer SC,
Keller MD, Chiu S,
Koppikar P,
Guryanova OA, Rapaport...
-
Etanercept Certolizumab Inflixamab Inflectra Interleukin 6
Tocilizumab Sarilumab J****
Kinase Tofacitnib Upadacitinib Baricitinib Ruxolitinib Fedratinib...
- berotralstat, conivaptan, crizotinib, diltiazem, dronedarone, duvelisib,
fedratinib, fluconazole, fosnetupitant,
grapefruit juice, imatinib, isavuconazonium...
